FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010560432> ?p ?o ?g. }

• W2010560432 endingPage "510" @default.
• W2010560432 startingPage "504" @default.
• W2010560432 abstract "Objective Clinical trials have demonstrated an increased risk of breast cancer during estrogen/norethisterone (NET) therapy. With this in mind, the effects of estrogen/NET combination on the proliferation of breast cancer cells overexpressing the progesterone receptor membrane component 1 (PGRMC1) were examined. The same combination was used for the first time in a mouse xenograft model to determine its effects on tumor development. Methods MCF-7 cells were stably transfected with PGRMC1 expression plasmid (WT-12 cells) or empty vector control (pcDNA-3HA). NET, medroxyprogesterone acetate (MPA), and progesterone were tested alone and sequentially and continuously combined with estradiol (E2). Six-week-old nude mice were inoculated with E2 pellets 24 hours before the injection of tumor cells into both flanks (n = 5-6 mice per group). After 8 days, animals were inoculated with a NET pellet or with placebo pellets, and tumor volumes were recorded twice a week. Results NET alone significantly increased the proliferation of WT-12 cells, MPA was effective only at the two highest concentrations, and progesterone had no effect. The twofold to threefold E2-induced increase (10−10 M) was not significantly influenced by the addition of the various progestogens. In contrast, 10−12 M E2 had no effect; however, addition of MPA and NET triggered a significant proliferative response. In vivo, a sequential combination of NET and E2 also significantly increased the tumor growth of WT-12 cells; empty vector cells did not respond to NET. Conclusions We have demonstrated for the first time that an E2/NET combination increases the proliferation of PGRMC1-overexpressing breast cancer cells, both in vivo and in vitro. Our results suggest that undetected tumor cells overexpressing PGRMC1 may be more likely to develop into frank tumor cells in women undergoing E2/NET hormone therapy." @default.
• W2010560432 created "2016-06-24" @default.
• W2010560432 creator A5011069826 @default.
• W2010560432 creator A5012894838 @default.
• W2010560432 creator A5026893077 @default.
• W2010560432 creator A5040233864 @default.
• W2010560432 creator A5040985806 @default.
• W2010560432 creator A5043943489 @default.
• W2010560432 creator A5061438971 @default.
• W2010560432 creator A5084397192 @default.
• W2010560432 creator A5085500989 @default.
• W2010560432 creator A5086791040 @default.
• W2010560432 date "2013-05-01" @default.
• W2010560432 modified "2023-09-26" @default.
• W2010560432 title "Overexpression of progesterone receptor membrane component 1" @default.
• W2010560432 cites W1586699954 @default.
• W2010560432 cites W1593442063 @default.
• W2010560432 cites W162054572 @default.
• W2010560432 cites W1969730619 @default.
• W2010560432 cites W1972628924 @default.
• W2010560432 cites W2012041763 @default.
• W2010560432 cites W2029202752 @default.
• W2010560432 cites W2033559611 @default.
• W2010560432 cites W2043755645 @default.
• W2010560432 cites W2047538251 @default.
• W2010560432 cites W2049413564 @default.
• W2010560432 cites W2051559140 @default.
• W2010560432 cites W2093073704 @default.
• W2010560432 cites W2094220317 @default.
• W2010560432 cites W2095201441 @default.
• W2010560432 cites W2100560126 @default.
• W2010560432 cites W2104231345 @default.
• W2010560432 cites W2111583754 @default.
• W2010560432 cites W2112181124 @default.
• W2010560432 cites W2121822533 @default.
• W2010560432 cites W2171253557 @default.
• W2010560432 cites W2318749571 @default.
• W2010560432 doi "https://doi.org/10.1097/gme.0b013e3182755c97" @default.
• W2010560432 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23615641" @default.
• W2010560432 hasPublicationYear "2013" @default.
• W2010560432 type Work @default.
• W2010560432 sameAs 2010560432 @default.
• W2010560432 citedByCount "32" @default.
• W2010560432 countsByYear W20105604322013 @default.
• W2010560432 countsByYear W20105604322014 @default.
• W2010560432 countsByYear W20105604322015 @default.
• W2010560432 countsByYear W20105604322016 @default.
• W2010560432 countsByYear W20105604322017 @default.
• W2010560432 countsByYear W20105604322018 @default.
• W2010560432 countsByYear W20105604322019 @default.
• W2010560432 countsByYear W20105604322020 @default.
• W2010560432 countsByYear W20105604322021 @default.
• W2010560432 countsByYear W20105604322022 @default.
• W2010560432 crossrefType "journal-article" @default.
• W2010560432 hasAuthorship W2010560432A5011069826 @default.
• W2010560432 hasAuthorship W2010560432A5012894838 @default.
• W2010560432 hasAuthorship W2010560432A5026893077 @default.
• W2010560432 hasAuthorship W2010560432A5040233864 @default.
• W2010560432 hasAuthorship W2010560432A5040985806 @default.
• W2010560432 hasAuthorship W2010560432A5043943489 @default.
• W2010560432 hasAuthorship W2010560432A5061438971 @default.
• W2010560432 hasAuthorship W2010560432A5084397192 @default.
• W2010560432 hasAuthorship W2010560432A5085500989 @default.
• W2010560432 hasAuthorship W2010560432A5086791040 @default.
• W2010560432 hasConcept C121608353 @default.
• W2010560432 hasConcept C126322002 @default.
• W2010560432 hasConcept C134018914 @default.
• W2010560432 hasConcept C150903083 @default.
• W2010560432 hasConcept C16685009 @default.
• W2010560432 hasConcept C207001950 @default.
• W2010560432 hasConcept C2776306185 @default.
• W2010560432 hasConcept C2777164284 @default.
• W2010560432 hasConcept C2778826759 @default.
• W2010560432 hasConcept C2779234561 @default.
• W2010560432 hasConcept C2781039349 @default.
• W2010560432 hasConcept C2908647359 @default.
• W2010560432 hasConcept C2986817661 @default.
• W2010560432 hasConcept C530470458 @default.
• W2010560432 hasConcept C54009773 @default.
• W2010560432 hasConcept C54355233 @default.
• W2010560432 hasConcept C71924100 @default.
• W2010560432 hasConcept C81885089 @default.
• W2010560432 hasConcept C84606932 @default.
• W2010560432 hasConcept C86803240 @default.
• W2010560432 hasConcept C98717036 @default.
• W2010560432 hasConcept C99454951 @default.
• W2010560432 hasConceptScore W2010560432C121608353 @default.
• W2010560432 hasConceptScore W2010560432C126322002 @default.
• W2010560432 hasConceptScore W2010560432C134018914 @default.
• W2010560432 hasConceptScore W2010560432C150903083 @default.
• W2010560432 hasConceptScore W2010560432C16685009 @default.
• W2010560432 hasConceptScore W2010560432C207001950 @default.
• W2010560432 hasConceptScore W2010560432C2776306185 @default.
• W2010560432 hasConceptScore W2010560432C2777164284 @default.
• W2010560432 hasConceptScore W2010560432C2778826759 @default.
• W2010560432 hasConceptScore W2010560432C2779234561 @default.
• W2010560432 hasConceptScore W2010560432C2781039349 @default.
• W2010560432 hasConceptScore W2010560432C2908647359 @default.

• next